Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis
Introduction Treatments that offer two medications in a fixed combination have the potential
to offer efficacious and safe treatment with advantages such as a regimen that is simpler
than administering two separate solutions. This study evaluated the safety and efficacy of
fixed-combination versus concomitant moxifloxacin 0.5% and dexamethasone 0.1% ocular
solutions for the treatment of bacterial ocular inflammation and infection. Methods The
clinical study design was a randomized, double-masked, active-controlled, parallel-group …
to offer efficacious and safe treatment with advantages such as a regimen that is simpler
than administering two separate solutions. This study evaluated the safety and efficacy of
fixed-combination versus concomitant moxifloxacin 0.5% and dexamethasone 0.1% ocular
solutions for the treatment of bacterial ocular inflammation and infection. Methods The
clinical study design was a randomized, double-masked, active-controlled, parallel-group …
Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.
R Belfort Júnior, L Gabriel, PJM Bispo, C Muccioli… - 2012 - cabidigitallibrary.org
Introduction: Treatments that offer two medications in a fixed combination have the potential
to offer efficacious and safe treatment with advantages such as a regimen that is simpler
than administering two separate solutions. This study evaluated the safety and efficacy of
fixed-combination versus concomitant moxifloxacin 0.5% and dexamethasone 0.1% ocular
solutions for the treatment of bacterial ocular inflammation and infection. Methods: The
clinical study design was a randomized, double-masked, active-controlled, parallel-group …
to offer efficacious and safe treatment with advantages such as a regimen that is simpler
than administering two separate solutions. This study evaluated the safety and efficacy of
fixed-combination versus concomitant moxifloxacin 0.5% and dexamethasone 0.1% ocular
solutions for the treatment of bacterial ocular inflammation and infection. Methods: The
clinical study design was a randomized, double-masked, active-controlled, parallel-group …